Search for other papers by Peter D Mark in
Google Scholar
PubMed
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Claus L Petersen in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Andreas Kjaer in
Google Scholar
PubMed
Department of Medicine O, Department of Clinical Physiology and Nuclear Medicine, Department of Clinical Physiology, Faculty of Health Sciences, Center for Functional and Diagnostic Imaging and Research, Centre of Endocrinology and Metabolism, Herlev University Hospital, Herlev Ringvej 75, Herlev DK‐2730, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Background Subclinical hyperthyroidism (SH) is defined by the biochemical pattern of reduced or undetectable serum thyroid-stimulating hormone (TSH) levels and thyroid hormone levels within the reference range. SH is seen with increasing frequency
Search for other papers by Fan Zhang in
Google Scholar
PubMed
Search for other papers by Jian Chen in
Google Scholar
PubMed
Search for other papers by Xinyue Lin in
Google Scholar
PubMed
Search for other papers by Shiqiao Peng in
Google Scholar
PubMed
Search for other papers by Xiaohui Yu in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
Introduction Thyroid hormones (THs) are vital for fetal neurodevelopment. The prevalence of subclinical hypothyroidism (SCH) in the general population is 4–10% and can reach 5% in pregnant women. Haddow et al . investigated the intelligence
Search for other papers by Jan Kvasnička in
Google Scholar
PubMed
Search for other papers by Ondřej Petrák in
Google Scholar
PubMed
Search for other papers by Tomáš Zelinka in
Google Scholar
PubMed
Search for other papers by Judita Klímová in
Google Scholar
PubMed
Search for other papers by Barbora Kološová in
Google Scholar
PubMed
Search for other papers by Květoslav Novák in
Google Scholar
PubMed
Search for other papers by David Michalský in
Google Scholar
PubMed
Search for other papers by Jiří Widimský Jr in
Google Scholar
PubMed
Search for other papers by Robert Holaj in
Google Scholar
PubMed
metabolism improves after adrenalectomy ( 50 , 51 ), it cannot be ruled out that subclinical involvement of LV may persist to some extent. Finally, the decline of GLS is well documented in patients with the systemic inflammatory response syndrome and the
Search for other papers by Sahar Hossam El Hini in
Google Scholar
PubMed
Search for other papers by Yehia Zakaria Mahmoud in
Google Scholar
PubMed
Search for other papers by Ahmed Abdelfadel Saedii in
Google Scholar
PubMed
Search for other papers by Sayed Shehata Mahmoud in
Google Scholar
PubMed
Search for other papers by Mohamed Ahmed Amin in
Google Scholar
PubMed
Search for other papers by Shereen Riad Mahmoud in
Google Scholar
PubMed
Search for other papers by Ragaa Abdelshaheed Matta in
Google Scholar
PubMed
Introduction Overt hypothyroidism (OH) and subclinical hypothyroidism (SCH) are characterized by the coexistence of traditional cardiovascular disease risk factors, insulin resistance (IR), elevated inflammatory markers, altered hemodynamic
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Trynke van der Boom in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Joop D Lefrandt in
Google Scholar
PubMed
the impact of overt and subclinical hyperthyroidism on the cardiovascular system. We will thereafter present the latest insights on the cardiac effects of thyroid suppression therapy for the treatment of thyroid cancer. Finally, we will show new
Search for other papers by Qingrong Pan in
Google Scholar
PubMed
Search for other papers by Shuxin Gao in
Google Scholar
PubMed
Search for other papers by Xia Gao in
Google Scholar
PubMed
Search for other papers by Ning Yang in
Google Scholar
PubMed
Search for other papers by Zhi Yao in
Google Scholar
PubMed
Search for other papers by Yanjin Hu in
Google Scholar
PubMed
Search for other papers by Li Miao in
Google Scholar
PubMed
Search for other papers by Zhe Chen in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism and clinical hypothyroidism, two commonly encountered clinical conditions, can induce various metabolic changes ( 1 ) and increase the risk of cardiovascular diseases ( 2 , 3 ). Recent researches have
Department of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China
Search for other papers by Ningning Gong in
Google Scholar
PubMed
Search for other papers by Cuixia Gao in
Google Scholar
PubMed
Search for other papers by Xuedi Chen in
Google Scholar
PubMed
Search for other papers by Yu Wang in
Google Scholar
PubMed
Search for other papers by Limin Tian in
Google Scholar
PubMed
Search for other papers by Xingyao Tang in
Google Scholar
PubMed
Search for other papers by Zhi-Hui Song in
Google Scholar
PubMed
Search for other papers by Dawei Wang in
Google Scholar
PubMed
Search for other papers by Jinkui Yang in
Google Scholar
PubMed
Search for other papers by Marly Augusto Cardoso in
Google Scholar
PubMed
Search for other papers by Jian-Bo Zhou in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
Search for other papers by Rafael Simó in
Google Scholar
PubMed
factor for dementia, promotes neurocognitive function and regulation metabolic processes ( 4 ). Thyroid dysfunction, including clinical hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, and clinical hypothyroidism, has been
Search for other papers by Qing Zhou in
Google Scholar
PubMed
Search for other papers by Li Yong Zhang in
Google Scholar
PubMed
Search for other papers by Mei Feng Dai in
Google Scholar
PubMed
Search for other papers by Zhen Li in
Google Scholar
PubMed
Search for other papers by Chao Chun Zou in
Google Scholar
PubMed
Search for other papers by Hui Liu in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism has been defined as an elevated serum thyroid-stimulating hormone (TSH) with normal free thyroxine levels ( 1 ). Despite maintaining normal thyroid hormone levels, patients with subclinical
Search for other papers by Kusum Lata in
Google Scholar
PubMed
Search for other papers by Pinaki Dutta in
Google Scholar
PubMed
Search for other papers by Subbiah Sridhar in
Google Scholar
PubMed
Search for other papers by Minakshi Rohilla in
Google Scholar
PubMed
Search for other papers by Anand Srinivasan in
Google Scholar
PubMed
Search for other papers by G R V Prashad in
Google Scholar
PubMed
Search for other papers by Viral N Shah in
Google Scholar
PubMed
Search for other papers by Anil Bhansali in
Google Scholar
PubMed
increased risk of progression to subclinical hypothyroidism, or it could be due to the transplacental transfer of thyroid receptor blocking antibodies (10, 11) . Hence, there is a need to screen for subclinical hypothyroidism and thyroid autoimmunity in